Fund Holdings

Saturn V Capital Management LP

Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
ALUMIS INC3,135,9533,202,075+66,12230,606,90170,541,71212.77%+39,934,811
IMMIX BIOPHARMA INC2,999,1693,693,585+694,41615,685,65433,648,5596.09%+17,962,905
CANDEL THERAPEUTICS INC02,896,588+2,896,588014,193,2812.57%+14,193,281
VAXCYTE INC(PCVX)798,940824,532+25,59236,863,09247,913,5558.68%+11,050,463
AMYLYX PHARMACEUTICALS INC(AMLX)4,496,4874,349,885-146,60254,317,56360,463,40210.95%+6,145,839
OVID THERAPEUTICS INC2,500,0004,166,666+1,666,6664,075,0009,249,9991.68%+5,174,999
DISC MEDICINE INC(IRON)298,429449,926+151,49723,698,24728,768,2685.21%+5,070,021
ZURA BIO LTD0739,960+739,96004,402,7620.80%+4,402,762
X4 PHARMACEUTICALS INC5,800,5306,456,646+656,11623,202,12026,665,9484.83%+3,463,828
OCULIS HOLDING AG516,761516,761010,319,71713,740,6752.49%+3,420,958
PHARVARIS N V
COM
1,140,0331,201,402+61,36931,635,91633,939,6066.15%+2,303,690
ALTO NEUROSCIENCE INC(ANRO)088,999+88,99902,000,6980.36%+2,000,698
SATELLOS BIOSCIENCE INC0350,000+350,00001,970,5000.36%+1,970,500
CELCUITY INC(CELC)317,095281,904-35,19131,627,05532,176,5235.83%+549,468
INVENTIVA SA(IVA)283,1660-283,1661,316,7220-1,316,722
INHIBIKASE THERAPEUTICS INC3,856,7993,863,445+6,6467,906,4386,490,5881.18%-1,415,850
MONOPAR THERAPEUTICS INC325,701345,626+19,92521,268,27518,936,8493.43%-2,331,426
INVIVYD INC7,735,38610,949,084+3,213,69819,106,40314,233,8092.58%-4,872,594
CENTESSA PHARMACEUTICALS PLC282,6920-282,6927,070,1270-7,070,127
JAZZ PHARMACEUTICALS PLC(JAZZ)248,070162,961-85,10942,171,90030,807,7775.58%-11,364,123
DYNE THERAPEUTICS INC(DYN)1,788,616966,609-822,00734,985,32917,524,6213.17%-17,460,708
OCULAR THERAPEUTIX INC(OCUL)1,504,8800-1,504,88018,269,2430-18,269,243
COGENT BIOSCIENCES INC(COGT)1,217,064626,635-590,42943,230,11324,119,1814.37%-19,110,932
ABIVAX SA(ABVX)649,179542,696-106,48387,545,03460,429,20010.94%-27,115,834
Page 1 of 1